Visipaque and dyspnoea Patient Reports March 12, 2010

Visipaque Side Effects Report #4604135-X
Visipaque side effect was reported by a Pharmacist from on Mar 09, 2005. Male patient, 64 years of age, weighting 142.5 lb, was diagnosed with scan with contrast and was treated with Visipaque. After drug was administered, patient experienced the following side effects: apnoea, contrast media reaction, depressed level of consciousness, dyspnoea, flushing, hyperhidrosis, oedema, urticaria. Visipaque dosage: 50 ML IV OTO. During the same period patient was treated with TOPROL, LIPITOR, NORVASC, PLAVIX, SOSORBIDE, MUCOMYST, XYLOCAINE. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #4571257-1
Visipaque side effect was reported by a Health Professional from on Jan 20, 2005. Female patient, 39 years of age, was diagnosed with pulmonary embolism  and was treated with Visipaque. After drug was administered, patient experienced the following side effects: acidosis, blood pressure increased, body temperature decreased, chest pain , cough, dyspnoea, heart rate increased, hypoxia, oedema peripheral. Visipaque dosage: 150 ML, SINGLE DOSE, IV. During the same period patient was treated with TYLENOL. Patient died on 09/18/2004.

Visipaque Side Effects Report #4571256-X
Visipaque side effect was reported by a Health Professional from on Jan 20, 2005. Female patient was diagnosed with pulmonary embolism  and was treated with Visipaque. After drug was administered, patient experienced the following side effects: cardiac arrest , coma, dyspnoea, lobar pneumonia, respiratory distress, resuscitation. Visipaque dosage: 150 ML SINGLE DOSE IV. Patient died on 10/01/2004.

Visipaque Side Effects Report #4705961-9
Visipaque side effect was reported by a Health Professional from on Dec 06, 2004. Female patient, 84 years of age, was diagnosed with pancreatic carcinoma and was treated with Visipaque. After drug was administered, patient experienced the following side effects: dyspnoea. Visipaque dosage: 150 ML, SINGLE DOSE, I.V.. During the same period patient was treated with PREDNISONE, BENADRYL. Patient was hospitalized. Patient recovered.


Visipaque Side Effects Report #5419198-1
Visipaque side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Female patient, 43 years of age, was diagnosed with nephrolithiasis and was treated with Visipaque. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, nausea . Visipaque dosage: 100ML 1 X IV. Patient recovered.

Visipaque Side Effects Report #4640998-X
Visipaque side effect was reported by a Consumer or non-health professional from on Apr 19, 2005. Male patient, 59 years of age, was diagnosed with intermittent claudication and was treated with Visipaque. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, post procedural complication. Visipaque dosage: unknown. Patient recovered.

Visipaque Side Effects Report #5315534-5
Visipaque side effect was reported by a Pharmacist from UNITED STATES on May 01, 2007. Female patient, 89 years of age, was diagnosed with computerised tomogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: convulsion, dyspnoea, electromechanical dissociation. Visipaque dosage: unknown. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #4903430-4
Visipaque side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2006. Female patient, 56 years of age, was diagnosed with computerised tomogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, oxygen saturation decreased. Visipaque dosage: unknown. Patient recovered.

Visipaque Side Effects Report #5650843-1
Visipaque side effect was reported by a Pharmacist from UNITED STATES on Mar 04, 2008. Female patient, 46 years of age, was diagnosed with computerised tomogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea, throat tightness. Visipaque dosage: unknown. Patient recovered.


Visipaque Side Effects Report #5477637-4
Visipaque side effect was reported by a Health Professional from NORWAY on Sept 28, 2007. Female patient, 54 years of age, was diagnosed with colon cancer and was treated with Visipaque. After drug was administered, patient experienced the following side effects: dyspnoea, hepatorenal syndrome, malaise, myalgia, oral herpes, pyrexia, vomiting. Visipaque dosage: 120 ML, SINGLE DOSE, I.V.. During the same period patient was treated with MEGLUMINE AMIDOTRIZOATE AND AMIDOTRIZOATE, VESIPAQUE. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #4808727-4
Visipaque side effect was reported by a Health Professional from UNITED STATES on Oct 21, 2005. Female patient, 64 years of age, was diagnosed with chest x-ray abnormal, computerised tomogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, hypersensitivity, hypoaesthesia, pharyngeal oedema, pruritus, sneezing. Visipaque dosage: 100ML. Patient was hospitalized. Patient recovered.

Visipaque Side Effects Report #5730398-3
Visipaque side effect was reported by a Health Professional from UNITED STATES on May 05, 2008. Male patient, 51 years of age, was diagnosed with arteriogram and was treated with Visipaque. After drug was administered, patient experienced the following side effects: dyspnoea, flushing, respiratory rate increased, tachycardia, throat tightness. Visipaque dosage: 50 ML 1 DOSE INTRA-ARTER. Patient recovered.

Visipaque Side Effects Report #5444296-6
Visipaque side effect was reported by a Pharmacist from UNITED STATES on Sept 04, 2007. Male patient, 65 years of age, was treated with Visipaque. After drug was administered, patient experienced the following side effects: blood pressure decreased, dyspnoea, erythema, heart rate increased, oxygen saturation decreased. Visipaque dosage: 165 ML ONCE IV. Patient was hospitalized. Patient recovered.